Court Denies Preliminary Injunction Motion Against Ariosa Diagnostics

Download PDF

SAN JOSE, Calif.; July 6, 2012 - /PR Newswire/ - Ariosa Diagnostics, a molecular diagnostics company, announced today that the United States District Court for the Northern District of California denied the preliminary injunction motion filed against Ariosa Diagnostics by Sequenom, Inc. In its preliminary injunction motion, Sequenom sought to enjoin Ariosa Diagnostics from offering or selling its HarmonyTM Prenatal Test, pending the ultimate resolution of the litigation between Ariosa Diagnostics and Sequenom. “Ariosa Diagnostics has vigorously opposed Sequenom’s drastic attempt to bar Ariosa from competing with our Harmony Prenatal Test, and we feel pleased and vindicated by the Court’s order denying Sequenom’s preliminary injunction motion,” said Dr. Ken Song, Ariosa Diagnostics’ Chief Executive Officer.